Jinwoo Seok
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jinwoo Seok has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Hee-Young Yoon
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, Republic of Korea
2 shared publications - Yang-Ki Kim
Department of Internal Medicine, Soonchunhyang University College of Medicine, Seoul, Korea
2 shared publications Bo-Young Lee
Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea
1 shared publicationGae-Eil Jang
Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea
1 shared publication- Hun-Gyu Hwang
Soonchunhyang University Bucheon Hospital
1 shared publication Hyun-Seok Jeong
Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea
1 shared publication
Latest Publications
- Open Access
- 24 June 2026
- Published by Taylor & Francis in Pulmonology
- Vol. 32 (1) , 2693393
Association between smoking and prognosis in idiopathic pulmonary fibrosis: A systematic review and meta-analysis
Although smoking is a well-established risk factor for idiopathic pulmonary fibrosis (IPF) development, its impact on clinical outcomes remains unclear. Is smoking associated with clinical outcomes of IPF? A systematic search of PubMed, Embase, and the Cochrane Library was conducted to identify studies reporting associations between smoking status and IPF outcomes, including mortality, acute exacerbation (AE), lung cancer development, and baseline lung function. Summary estimates with 95% confidence intervals (CIs) were pooled using random-effects model. Subgroup analyses were conducted by study region. Forty-nine studies comprising 32 974 patients were included. Overall mortality did not differ by smoking status. However, significant regional differences were observed, with ever smokers demonstrating higher mortality in non - East Asian studies (Hazard ratio [HR] 1.17, 95% CI: 1.03-1.33) but lower mortality in East Asian studies (HR 0.75, 95% CI: 0.62-0.91, p-for-interaction < 0.001) compared with never smokers. Current smokers had a higher risk of developing lung cancer compared with non-current smokers (HR 1.88, 95% CI: 1.24-2.87). No significant associations were observed between smoking and the risk of AEs or baseline forced vital capacity. Smoking was not associated with overall mortality in IPF, although significant regional differences were observed.
- 24 June 2026
- Published by Taylor & Francis in Pulmonology
- Vol. 32 (1) , 2693393
Open AccessAssociation between smoking and prognosis in idiopathic pulmonary fibrosis: A systematic review and meta-analysis
Although smoking is a well-established risk factor for idiopathic pulmonary fibrosis (IPF) development, its impact on clinical outcomes remains unclear. Is smoking associated with clinical outcomes of IPF? A systematic search of PubMed, Embase, and the Cochrane Library was conducted to identify studies reporting associations between smoking status and IPF outcomes, including mortality, acute exacerbation (AE), lung cancer development, and baseline lung function. Summary estimates with 95% confidence intervals (CIs) were pooled using random-effects model. Subgroup analyses were conducted by study region. Forty-nine studies comprising 32 974 patients were included. Overall mortality did not differ by smoking status. However, significant regional differences were observed, with ever smokers demonstrating higher mortality in non - East Asian studies (Hazard ratio [HR] 1.17, 95% CI: 1.03-1.33) but lower mortality in East Asian studies (HR 0.75, 95% CI: 0.62-0.91, p-for-interaction < 0.001) compared with never smokers. Current smokers had a higher risk of developing lung cancer compared with non-current smokers (HR 1.88, 95% CI: 1.24-2.87). No significant associations were observed between smoking and the risk of AEs or baseline forced vital capacity. Smoking was not associated with overall mortality in IPF, although significant regional differences were observed.
- Open Access
- 10 July 2025
- Published by Korean Medical Association in Journal of the Korean Medical Association
- Vol. 68 (7) , 442-448
Clinical strategies for perioperative management of direct oral anticoagulants in patients treated for venous thromboembolism
Purpose: Venous thromboembolism (VTE) is increasing in prevalence in Korea. Direct oral anticoagulants (DOACs)—including apixaban, rivaroxaban, edoxaban, and dabigatran—are now the standard treatment of VTE. A growing number of patients on these agents require procedures or surgery, yet optimal perioperative management remains unclear.Current Concepts: Appropriate perioperative management of DOACs is essential to minimize both bleeding and thromboembolic complications. Procedure-related hemorrhagerisk can be categorized as minimal (e.g., minor dental or cataract procedures), low to moderate (e.g., arthroscopy, cutaneous or lymph node biopsies, laparoscopic cholecystectomy, or inguinal hernia repair), or high risk (e.g., cancer or orthopedic surgery). Given the rapid onset and short half-life of DOACs, bridging therapy is rarely needed. For procedures with minimal bleeding risk, DOACs can generally be continued or withheld only on the day of the procedure. For low to moderate bleeding risk, the recommendation is to stop DOACs one day before and resume one day after the procedure. For high-risk procedures, DOACs should be discontinued two days prior and restarted two days post-procedure.Discussion and Conclusion: With Korea’s aging population and improved cancer survival rates, clinicians are increasingly encountering patients on DOACs in the perioperative setting. However, some practitioners continue to rely on outdated practices based on warfarin or antiplatelet therapy. Improved outcomes require individualized DOAC management, tailored according to the specific agent, procedure-related bleeding risk, thromboembolic risk, and renal function. Promoting adherence to current, evidence-based protocols will optimize safety and efficacy for patients undergoing procedures while receiving DOAC therapy.
- 10 July 2025
- Published by Korean Medical Association in Journal of the Korean Medical Association
- Vol. 68 (7) , 442-448
Open AccessClinical strategies for perioperative management of direct oral anticoagulants in patients treated for venous thromboembolism
Purpose: Venous thromboembolism (VTE) is increasing in prevalence in Korea. Direct oral anticoagulants (DOACs)—including apixaban, rivaroxaban, edoxaban, and dabigatran—are now the standard treatment of VTE. A growing number of patients on these agents require procedures or surgery, yet optimal perioperative management remains unclear.Current Concepts: Appropriate perioperative management of DOACs is essential to minimize both bleeding and thromboembolic complications. Procedure-related hemorrhagerisk can be categorized as minimal (e.g., minor dental or cataract procedures), low to moderate (e.g., arthroscopy, cutaneous or lymph node biopsies, laparoscopic cholecystectomy, or inguinal hernia repair), or high risk (e.g., cancer or orthopedic surgery). Given the rapid onset and short half-life of DOACs, bridging therapy is rarely needed. For procedures with minimal bleeding risk, DOACs can generally be continued or withheld only on the day of the procedure. For low to moderate bleeding risk, the recommendation is to stop DOACs one day before and resume one day after the procedure. For high-risk procedures, DOACs should be discontinued two days prior and restarted two days post-procedure.Discussion and Conclusion: With Korea’s aging population and improved cancer survival rates, clinicians are increasingly encountering patients on DOACs in the perioperative setting. However, some practitioners continue to rely on outdated practices based on warfarin or antiplatelet therapy. Improved outcomes require individualized DOAC management, tailored according to the specific agent, procedure-related bleeding risk, thromboembolic risk, and renal function. Promoting adherence to current, evidence-based protocols will optimize safety and efficacy for patients undergoing procedures while receiving DOAC therapy.
- Open Access
- 1 July 2024
- Published by The Korean Academy of Tuberculosis and Respiratory Diseases in Tuberculosis and Respiratory Diseases
- Vol. 87 (3) , 357-367
Association between the Risk of Obstructive Sleep Apnea and Lung Function: Korea National Health and Nutrition Examination Survey
Background: Obstructive sleep apnea (OSA) is a prevalent sleep disorder associated with various health issues. Although some studies have suggested an association between reduced lung function and OSA, this association remains unclear. Our study aimed to explore this relationship using data from a nationally representative population- based survey.Methods: We performed an analysis of data from the 2019 Korea National Health and Nutrition Examination Survey. Our study encompassed 3,675 participants aged 40 years and older. Risk of OSA was assessed using the STOP-Bang (Snoring, Tiredness during daytime, Observed apnea, and high blood Pressure-Body mass index, Age, Neck circumference, Gender) questionnaire and lung function tests were performed using a portable spirometer. Logistic regression analysis was applied to identify the risk factors associated with a high-risk of OSA, defined as a STOP-Bang score of ≥3.Results: Of 3,675 participants, 600 (16.3%) were classified into high-risk OSA group. Participants in the high-risk OSA group were older, had a higher body mass index, and a higher proportion of males and ever-smokers. They also reported lower lung function and quality of life index in various domains along with increased respiratory symptoms. Univariate logistic regression analysis indicated a significant association between impaired lung function and a high-risk of OSA. However, in the multivariable analysis, only chronic cough (odds ratio [OR], 2.413; 95% confidence interval [CI], 1.383 to 4.213) and sputum production (OR, 1.868; 95% CI, 1.166 to 2.992) remained significantly associated with a high OSA risk.Conclusion: Our study suggested that, rather than baseline lung function, chronic cough, and sputum production are more significantly associated with OSA risk.
- 1 July 2024
- Published by The Korean Academy of Tuberculosis and Respiratory Diseases in Tuberculosis and Respiratory Diseases
- Vol. 87 (3) , 357-367
Open AccessAssociation between the Risk of Obstructive Sleep Apnea and Lung Function: Korea National Health and Nutrition Examination Survey
Background: Obstructive sleep apnea (OSA) is a prevalent sleep disorder associated with various health issues. Although some studies have suggested an association between reduced lung function and OSA, this association remains unclear. Our study aimed to explore this relationship using data from a nationally representative population- based survey.Methods: We performed an analysis of data from the 2019 Korea National Health and Nutrition Examination Survey. Our study encompassed 3,675 participants aged 40 years and older. Risk of OSA was assessed using the STOP-Bang (Snoring, Tiredness during daytime, Observed apnea, and high blood Pressure-Body mass index, Age, Neck circumference, Gender) questionnaire and lung function tests were performed using a portable spirometer. Logistic regression analysis was applied to identify the risk factors associated with a high-risk of OSA, defined as a STOP-Bang score of ≥3.Results: Of 3,675 participants, 600 (16.3%) were classified into high-risk OSA group. Participants in the high-risk OSA group were older, had a higher body mass index, and a higher proportion of males and ever-smokers. They also reported lower lung function and quality of life index in various domains along with increased respiratory symptoms. Univariate logistic regression analysis indicated a significant association between impaired lung function and a high-risk of OSA. However, in the multivariable analysis, only chronic cough (odds ratio [OR], 2.413; 95% confidence interval [CI], 1.383 to 4.213) and sputum production (OR, 1.868; 95% CI, 1.166 to 2.992) remained significantly associated with a high OSA risk.Conclusion: Our study suggested that, rather than baseline lung function, chronic cough, and sputum production are more significantly associated with OSA risk.
- Open Access
- 31 December 2019
- Published by The Korean Society of Blood Transfusion in The Korean Journal of Blood Transfusion
- Vol. 30 (3) , 246-252
Rifampin-Induced Immune Hemolytic Anemia during Treatment of Pulmonary Tuberculosis in a Patient with Primary Sjogren's Syndrome
Jin-Woo Souk, Yang-Ki Kim, Gae-Eil Jang, Hyun-Seok Jeong, Soo-Taek Uh, Ki-Up Kim, So-My Koo, Bo-Young Lee, Hyunjin Noh, Woo Yong Shin, Jeong Won Shin, So-Young Jin. KJBT 2019;30:246-52. https://doi.org/10.17945/kjbt.2019.30.3.246
- 31 December 2019
- Published by The Korean Society of Blood Transfusion in The Korean Journal of Blood Transfusion
- Vol. 30 (3) , 246-252
Open AccessRifampin-Induced Immune Hemolytic Anemia during Treatment of Pulmonary Tuberculosis in a Patient with Primary Sjogren's Syndrome
Jin-Woo Souk, Yang-Ki Kim, Gae-Eil Jang, Hyun-Seok Jeong, Soo-Taek Uh, Ki-Up Kim, So-My Koo, Bo-Young Lee, Hyunjin Noh, Woo Yong Shin, Jeong Won Shin, So-Young Jin. KJBT 2019;30:246-52. https://doi.org/10.17945/kjbt.2019.30.3.246
- Open Access
- 1 September 2019
- Published by Korean Association of Internal Medicine in The Korean Journal of Internal Medicine
- Vol. 34 (5) , 1169-1170
Effects of botulinum toxin injection on systemic sclerosis-related digital ulcers
- 1 September 2019
- Published by Korean Association of Internal Medicine in The Korean Journal of Internal Medicine
- Vol. 34 (5) , 1169-1170
Open AccessEffects of botulinum toxin injection on systemic sclerosis-related digital ulcers